INHIBITION OF GLUTAMINYL CYCLASE ENHANCES INACTIVATION OF CCL2: A POTENTIAL THERAPY FOR CARDIOVASCULAR DISEASE

被引：0
|
作者：
Cynis, H. [1 ]
Hoffmann, T. [2 ]
Schilling, S. [1 ]
Demuth, H-U
机构：
[1] Probiodrug AG, Enzymol, Halle, Germany
[2] Probiodrug AG, In Vitro Pharmacol, Halle, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] INTERRUPTION OF CCL2 INHIBITION ENHANCES METASTATIC DISEASE
    不详
    CANCER DISCOVERY, 2014, 4 (12) : 1364 - 1364
  • [2] Rb inactivation enhances tumor progression by elevating CCL2 expression
    Li, Fengkai
    Kitajima, Shunsuke
    Mukaida, Naofumi
    Takahashi, Chiaki
    CYTOKINE, 2017, 100 : 189 - 190
  • [3] Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
    Tu, Megan M.
    Abdel-Hafiz, Hany A.
    Jones, Robert T.
    Jean, Annie
    Hoff, Katelyn J.
    Duex, Jason E.
    Chauca-Diaz, Ana
    Costello, James C.
    Dancik, Garrett M.
    Tamburini, Beth A. Jiron
    Czerniak, Bogdan
    Kaye, Jonathan
    Theodorescu, Dan
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [4] Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
    Megan M. Tu
    Hany A. Abdel-Hafiz
    Robert T. Jones
    Annie Jean
    Katelyn J. Hoff
    Jason E. Duex
    Ana Chauca-Diaz
    James C. Costello
    Garrett M. Dancik
    Beth A. Jirón Tamburini
    Bogdan Czerniak
    Jonathan Kaye
    Dan Theodorescu
    Communications Biology, 3
  • [5] Glutaminyl cyclase inhibition reduces Alzheimer disease pathology and symptoms
    Nature Clinical Practice Neurology, 2009, 5 (1): : 2 - 2
  • [6] CCL2 inhibition is renoprotective in diabetic nephropathy
    Nature Reviews Nephrology, 2014, 10 (8) : 422 - 422
  • [7] INHIBITION OF GLUTAMINYL CYCLASE TARGETING NEURODEGENERATION AND NEUROINFLAMMATION IN ALZHEIMER'S DISEASE
    Demuth, Hans-Ulrich
    Schilling, S.
    Cynis, H.
    Heiser, U.
    Manhart, S.
    Graubner, S.
    Alexandru, A.
    Jagla, W.
    Lues, I.
    Weber, F.
    Glund, K.
    NEUROBIOLOGY OF AGING, 2012, 33 : S7 - S7
  • [8] Atheroprotective Roles of Adiponectin via CCL2 Inhibition
    Fujita, Makoto
    Yamamoto, Hiroyasu
    Yoshida, Nao
    Ono, Runa
    Matsuoka, Tetsuro
    Kihara, Shinji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (11) : 1204 - 1213
  • [9] Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
    Stephan Schilling
    Ulrike Zeitschel
    Torsten Hoffmann
    Ulrich Heiser
    Mike Francke
    Astrid Kehlen
    Max Holzer
    Birgit Hutter-Paier
    Manuela Prokesch
    Manfred Windisch
    Wolfgang Jagla
    Dagmar Schlenzig
    Christiane Lindner
    Thomas Rudolph
    Gunter Reuter
    Holger Cynis
    Dirk Montag
    Hans-Ulrich Demuth
    Steffen Rossner
    Nature Medicine, 2008, 14 : 1106 - 1111
  • [10] Glycosylation enhances functional stability of the chemotactic cytokine CCL2
    Ruggiero, P
    Flati, S
    Di Cioccio, V
    Maurizi, G
    Macchia, G
    Facchin, A
    Anacardio, R
    Maras, A
    Lucarelli, M
    Boraschi, D
    EUROPEAN CYTOKINE NETWORK, 2003, 14 (02) : 91 - 96
12345